167 related articles for article (PubMed ID: 23954579)
1. Extent of HCV NS3 protease variability and resistance-associated mutations assessed by next generation sequencing in HCV monoinfected and HIV/HCV coinfected patients.
Bartolini B; Giombini E; Zaccaro P; Selleri M; Rozera G; Abbate I; Comandini UV; Ippolito G; Solmone M; Capobianchi MR
Virus Res; 2013 Nov; 177(2):205-8. PubMed ID: 23954579
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus (HCV) protease variability and anti-HCV protease inhibitor resistance in HIV/HCV-coinfected patients.
Trimoulet P; Belzunce C; Faure M; Wittkop L; Reigadas S; Dupon M; Ragnaud JM; Fleury H; Neau D
HIV Med; 2011 Sep; 12(8):506-9. PubMed ID: 21410862
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV-1 co-infected patients.
Nevot M; Boesecke C; Parera M; Andrés C; Franco S; Revollo B; Ingiliz P; Tural C; Clotet B; Rockstroh JK; Martinez MA;
J Viral Hepat; 2014 Jun; 21(6):e19-28. PubMed ID: 24674023
[TBL] [Abstract][Full Text] [Related]
4. Resistance mutations are rare among protease inhibitor treatment-naive hepatitis C genotype-1 patients with or without HIV coinfection.
Lisboa-Neto G; Noble CF; Pinho JR; Malta FM; Gomes-Gouvêa MS; Alvarado-Mora MV; da Silva MH; Leite AG; Piccoli LZ; Rodrigues FK; Carrilho FJ; Mendes-Correa MC
Antivir Ther; 2015; 20(3):281-7. PubMed ID: 25279715
[TBL] [Abstract][Full Text] [Related]
5. Naturally occurring hepatitis C virus (HCV) NS3/4A protease inhibitor resistance-related mutations in HCV genotype 1-infected subjects in Italy.
Vicenti I; Rosi A; Saladini F; Meini G; Pippi F; Rossetti B; Sidella L; Di Giambenedetto S; Almi P; De Luca A; Caudai C; Zazzi M
J Antimicrob Chemother; 2012 Apr; 67(4):984-7. PubMed ID: 22258932
[TBL] [Abstract][Full Text] [Related]
6. Genetic heterogeneity of the NS3 protease gene in hepatitis C virus genotype 1 from untreated infected patients.
Vallet S; Gouriou S; Nousbaum JB; Legrand-Quillien MC; Goudeau A; Picard B
J Med Virol; 2005 Apr; 75(4):528-37. PubMed ID: 15714495
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of hepatitis C virus for determination of subtypes and detection of resistance mutations to protease inhibitors in a group of intravenous drug users co-infected with HIV.
Silva T; Cortes Martins H; Coutinho R; Leitão E; Silva R; Pádua E
J Med Virol; 2015 Sep; 87(9):1549-57. PubMed ID: 25940586
[TBL] [Abstract][Full Text] [Related]
8. Previous failure of interferon-based therapy does not alter the frequency of HCV NS3 protease or NS5B polymerase inhibitor resistance-associated variants: longitudinal analysis in HCV/HIV co-infected patients.
Sede MM; Laufer NL; Quarleri J
Int J Antimicrob Agents; 2015 Aug; 46(2):219-24. PubMed ID: 26100213
[TBL] [Abstract][Full Text] [Related]
9. Diversity of 1,213 hepatitis C virus NS3 protease sequences from a clinical virology laboratory database in Marseille university hospitals, southeastern France.
Hajji H; Aherfi S; Motte A; Ravaux I; Mokhtari S; Ruiz JM; Poizot-Martin I; Tourres C; Tivoli N; Gérolami R; Tamalet C; Colson P
J Med Virol; 2015 Nov; 87(11):1921-33. PubMed ID: 25959702
[TBL] [Abstract][Full Text] [Related]
10. HCV NS3 quasispecies in liver and plasma and dynamics of telaprevir-resistant variants in breakthrough patients assessed by UDPS: A case study.
Bartolini B; Selleri M; Garbuglia AR; Giombini E; Taibi C; Lionetti R; D'Offizi G; Capobianchi MR
J Clin Virol; 2015 Nov; 72():60-5. PubMed ID: 26418073
[TBL] [Abstract][Full Text] [Related]
11. HCV NS3 naturally occurring variants in HIV/HCV coinfected DAA-naïve patients: consideration for HCV genotyping resistance testing.
Ruggiero T; Burdino E; Calcagno A; Bonora S; Boglione L; Di Perri G; Ghisetti V
Infection; 2016 Dec; 44(6):789-792. PubMed ID: 27522673
[TBL] [Abstract][Full Text] [Related]
12. Ultra-Deep Genomic Sequencing of HCV NS5A Resistance-Associated Substitutions in HCV/HIV Coinfected Patients.
Abdel-Hameed EA; Rouster SD; Boyce CL; Zhang X; Biesiada J; Medvedovic M; Sherman KE
Dig Dis Sci; 2018 Mar; 63(3):645-652. PubMed ID: 29330726
[TBL] [Abstract][Full Text] [Related]
13. Impact of highly active antiretroviral therapy on hepatitis C virus protease quasispecies diversity in HIV co-infected patients.
Winters MA; Chary A; Eison R; Asmuth D; Holodniy M
J Med Virol; 2010 May; 82(5):791-8. PubMed ID: 20336744
[TBL] [Abstract][Full Text] [Related]
14. Deconvoluting the composition of low-frequency hepatitis C viral quasispecies: comparison of genotypes and NS3 resistance-associated variants between HCV/HIV coinfected hemophiliacs and HCV monoinfected patients in Japan.
Ogishi M; Yotsuyanagi H; Tsutsumi T; Gatanaga H; Ode H; Sugiura W; Moriya K; Oka S; Kimura S; Koike K
PLoS One; 2015; 10(3):e0119145. PubMed ID: 25748426
[TBL] [Abstract][Full Text] [Related]
15. NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C.
D'Aliberti D; Cacciola I; Musolino C; Raffa G; Filomia R; Alibrandi A; Benfatto S; Beninati C; Saitta C; Giosa D; Romeo O; Raimondo G; Pollicino T
Intervirology; 2018; 61(1):1-8. PubMed ID: 30021203
[TBL] [Abstract][Full Text] [Related]
16. NS3 protease polymorphism and natural resistance to protease inhibitors in French patients infected with HCV genotypes 1-5.
Vallet S; Viron F; Henquell C; Le Guillou-Guillemette H; Lagathu G; Abravanel F; Trimoulet P; Soussan P; Schvoerer E; Rosenberg A; Gouriou S; Colson P; Izopet J; Payan C;
Antivir Ther; 2011; 16(7):1093-102. PubMed ID: 22024525
[TBL] [Abstract][Full Text] [Related]
17. Similarities between Human Immunodeficiency Virus Type 1 and Hepatitis C Virus Genetic and Phenotypic Protease Quasispecies Diversity.
Martinez MA; Nevot M; Jordan-Paiz A; Franco S
J Virol; 2015 Oct; 89(19):9758-64. PubMed ID: 26178979
[TBL] [Abstract][Full Text] [Related]
18. Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important?
Halfon P; Sarrazin C
Liver Int; 2012 Feb; 32 Suppl 1():79-87. PubMed ID: 22212577
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus resistance to protease inhibitors.
Halfon P; Locarnini S
J Hepatol; 2011 Jul; 55(1):192-206. PubMed ID: 21284949
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms associated with resistance to protease inhibitors in naïve patients infected with hepatitis C virus genotype 1 in Argentina: Low prevalence of Q80K.
Martínez AP; Culasso ACA; Pérez PS; Romano V; Campos RH; Ridruejo E; García G; Di Lello FA
Virus Res; 2017 Aug; 240():140-146. PubMed ID: 28837817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
